Innovation Pharmaceuticals Company Insiders
| IPIX Stock | USD 0.0003 0.0001 25.00% |
Innovation Pharmaceuticals employs about 4 people. The company is managed by 4 executives with a total tenure of roughly 10 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Break down of Innovation Pharmaceuticals' management performance can provide insight into the company performance.
| Leo CPA Insider CEO, Chairman |
| MS MP Insider VP Management |
Innovation |
Innovation Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (0.3177) % which means that it has lost $0.3177 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0946) %, meaning that it created substantial loss on money invested by shareholders. Innovation Pharmaceuticals' management efficiency ratios could be used to measure how well Innovation Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Innovation Pharmaceuticals Workforce Comparison
Innovation Pharmaceuticals is rated fourth overall in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 503. Innovation Pharmaceuticals maintains roughly 4.0 in number of employees contributing less than 1% to equities under Health Care industry.
Innovation Pharmaceuticals Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Innovation Pharmaceuticals Price Series Summation is a cross summation of Innovation Pharmaceuticals price series and its benchmark/peer.
Innovation Pharmaceuticals Notable Stakeholders
An Innovation Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Innovation Pharmaceuticals often face trade-offs trying to please all of them. Innovation Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Innovation Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Leo CPA | CEO, Chairman | Profile | |
| MS MP | VP Management | Profile | |
| Jim Boeheim | B Advisor | Profile | |
| James Alexander | Consultant | Profile |
About Innovation Pharmaceuticals Management Performance
The success or failure of an entity such as Innovation Pharmaceuticals often depends on how effective the management is. Innovation Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Innovation management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Innovation management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts. Innovation Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 4 people.
Please note, the imprecision that can be found in Innovation Pharmaceuticals' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Innovation Pharmaceuticals. Check Innovation Pharmaceuticals' Beneish M Score to see the likelihood of Innovation Pharmaceuticals' management manipulating its earnings.
Innovation Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Innovation Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Innovation Pharmaceuticals within its industry.Innovation Pharmaceuticals Manpower Efficiency
Return on Innovation Pharmaceuticals Manpower
| Revenue Per Employee | 4.5K | |
| Revenue Per Executive | 4.5K | |
| Net Loss Per Employee | 1.8M | |
| Net Loss Per Executive | 1.8M | |
| Working Capital Per Employee | 11.2K | |
| Working Capital Per Executive | 11.2K |
Additional Tools for Innovation Pink Sheet Analysis
When running Innovation Pharmaceuticals' price analysis, check to measure Innovation Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovation Pharmaceuticals is operating at the current time. Most of Innovation Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Innovation Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovation Pharmaceuticals' price. Additionally, you may evaluate how the addition of Innovation Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.